Cable Hill Partners, LLC Mustang Bio, Inc. Transaction History

Cable Hill Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$2.3 - $5.78 $229 - $578	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.71 - $7.58 $2,284 - $3,032	-400 Reduced 80.0%	100 $1,000
Q1 2018 Apr 20, 2018	SELL	$10.14 - $12.38 $2,028 - $2,476	-200 Reduced 28.57%	500 $5,000
Q4 2017 Feb 22, 2018	BUY	$8.75 - $11.99 $6,125 - $8,393	700	700 $8,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.